Literature DB >> 35530969

Erratum to lipid mediator lipoxin A4 and its analog BML-111 exert antitumor effects in melanoma.

.   

Abstract

[This corrects the article DOI: 10.21037/atm-21-1873.]. 2022 Annals of Translational Medicine. All rights reserved.

Entities:  

Year:  2022        PMID: 35530969      PMCID: PMC9073786          DOI: 10.21037/atm-2022-6

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


In the article (1) entitled “Lipid mediator lipoxin A4 and its analog BML-111 exert antitumor effects in melanoma” (doi:10.21037/atm-21-1873), the fourth author “Zhu Shen” should be removed from the authorship and the authorship should be corrected as follows: Yu Du1,2#, Jianing Yang2,3#, Tangfeng Su4#, Juan Li2,3. The author’s affiliation remain intact and the author contribution should be corrected as: (I) Conception and design: J Li; (II) Administrative support: None; (III) Provision of study materials or patients: J Yang; (IV) Collection and assembly of data: Y Du; (V) Data analysis and interpretation: T Su; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. The authors regret the error due to a lack of communication before publication by listing Zhu Shen in the authorship without his consent. The authors confirmed this error did not affect either the results or the conclusions of the paper. Below is the correct authorship information: Yu Du1,2#, Jianing Yang2,3#, Tangfeng Su4#, Juan Li2,3 1Department of Anesthesiology, Sichuan Provincial People’s Hospital, University of Electronic and Technology of China, Chengdu, China; 2Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, China; 3Department of Dermatology, Sichuan Provincial People’s Hospital, University of Electronic and Technology of China, Chengdu, China; 4Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China Contributions: (I) Conception and design: J Li; (II) Administrative support: None; (III) Provision of study materials or patients: J Yang; (IV) Collection and assembly of data: Y Du; (V) Data analysis and interpretation: T Su; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Click here to view the updated version of the article.
  1 in total

1.  Lipid mediator lipoxin A4 and its analog BML-111 exert antitumor effects in melanoma.

Authors:  Yu Du; Jianing Yang; Tangfeng Su; Zhu Shen; Juan Li
Journal:  Ann Transl Med       Date:  2021-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.